Solvonis Therapeutics plc (LON:SVNS)
London · Delayed Price · Currency is GBP · Price in GBX 0.2800
+0.0250 (9.80%)
Apr 17, 2026, 5:06 PM GMT
Solvonis Therapeutics Market Cap
Solvonis Therapeutics has a market cap or net worth of 19.06 million as of April 17, 2026. Its market cap has increased by 427.03% in one year.
Market Cap
19.06M
Enterprise Value
17.42M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.28
Market Cap Chart
Since January 6, 2022, Solvonis Therapeutics's market cap has decreased from 23.03M to 19.06M, a decrease of -17.25%. That is a compound annual growth rate of -4.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 19.06M | -9.68% |
| Dec 31, 2025 | 21.10M | 348.30% |
| Dec 31, 2024 | 4.71M | 686.33% |
| Dec 29, 2023 | 598.56K | -95.86% |
| Dec 30, 2022 | 14.47M | -37.18% |
| Jan 6, 2022 | 23.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| The Weir Group | 7.91B |
| Smiths Group | 7.84B |
| IMI plc | 6.89B |
| Melrose Industries | 6.75B |
| Spirax Group | 5.53B |
| Rotork | 2.79B |
| Bodycote | 1.20B |
| Goodwin | 991.27M |